Ligand validation:3RJ9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 3RJ9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RJ9_NAD_A_850	90%	46%	0.09	0.973	0.85	1.26	2	4	0	0	100%	1
3RJ9_NAD_C_850	90%	51%	0.088	0.969	0.75	1.13	1	2	2	0	100%	1
3RJ9_NAD_B_850	87%	49%	0.089	0.962	0.8	1.15	1	2	0	0	100%	1
3RJ9_NAD_D_850	87%	46%	0.09	0.961	0.83	1.27	1	5	0	0	100%	1
3RJ9_NAD_E_850	86%	49%	0.09	0.96	0.77	1.22	2	4	0	0	100%	1
3RJ9_NAD_F_850	59%	49%	0.129	0.913	0.73	1.25	-	3	0	0	100%	1
3RJ5_NAD_A_850	93%	52%	0.081	0.975	0.76	1.09	-	2	0	0	100%	1
1SBY_NAD_A_1255	83%	40%	0.116	0.976	1.19	1.23	4	4	1	0	100%	0.6
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.